January 11-15, 2027 | San Francisco
2027 Participating Companies
Pinetree Therapeutics is a biotechnology company developing bispecific antibody-based targeted protein degraders through its proprietary AbReptor™ platform to address drug resistance and prevent tumor recurrence.